Follow
Polyzois Makras
Polyzois Makras
251 Hellenic Air Force & VA General Hospital
Verified email at internet.gr
Title
Cited by
Cited by
Year
Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net
M Girschikofsky, M Arico, D Castillo, A Chu, C Doberauer, J Fichter, ...
Orphanet journal of rare diseases 8, 1-11, 2013
4042013
Clinical features of 24 patients with rebound‐associated vertebral fractures after denosumab discontinuation: systematic review and additional cases
AD Anastasilakis, SA Polyzos, P Makras, B Aubry‐Rozier, S Kaouri, ...
Journal of Bone and Mineral Research 32 (6), 1291-1296, 2017
3192017
Irisin in metabolic diseases
SA Polyzos, AD Anastasilakis, ZA Efstathiadou, P Makras, N Perakakis, ...
Endocrine 59, 260-274, 2018
2502018
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues
GA Kaltsas, D Papadogias, P Makras, AB Grossman
Endocrine-related cancer 12 (4), 683-699, 2005
2242005
Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 …
AD Anastasilakis, SA Polyzos, P Makras, A Gkiomisi, I Bisbinas, ...
Osteoporosis International 25, 1633-1642, 2014
1492014
Endocrine manifestations in Langerhans cell histiocytosis
P Makras, KI Alexandraki, GP Chrousos, AB Grossman, GA Kaltsas
Trends in Endocrinology & Metabolism 18 (6), 252-257, 2007
1282007
Zoledronate for the prevention of bone loss in women discontinuing denosumab treatment. A prospective 2‐year clinical trial
AD Anastasilakis, SE Papapoulos, SA Polyzos, NM Appelman‐Dijkstra, ...
Journal of Bone and Mineral Research 34 (12), 2220-2228, 2019
1222019
Therapy of endocrine disease: denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis
AD Anastasilakis, SA Polyzos, P Makras
European journal of endocrinology 179 (1), R31-R45, 2018
1192018
Denosumab discontinuation and the rebound phenomenon: a narrative review
AD Anastasilakis, P Makras, MP Yavropoulou, G Tabacco, AM Naciu, ...
Journal of clinical medicine 10 (1), 152, 2021
1072021
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
AD Anastasilakis, KA Toulis, SA Polyzos, CD Anastasilakis, P Makras
Therapeutics and Clinical Risk Management, 295-306, 2012
1052012
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and …
P Hadji, N Papaioannou, E Gielen, M Feudjo Tepie, E Zhang, I Frieling, ...
Osteoporosis International 26, 2479-2489, 2015
1022015
Novel therapies for osteoporosis
P Makras, S Delaroudis, AD Anastasilakis
Metabolism 64 (10), 1199-1214, 2015
952015
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
G Goyal, A Tazi, RS Go, KL Rech, JL Picarsic, R Vassallo, JR Young, ...
Blood, The Journal of the American Society of Hematology 139 (17), 2601-2621, 2022
942022
Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fractures
MP Yavropoulou, AD Anastasilakis, P Makras, DG Tsalikakis, ...
European Journal of Endocrinology 176 (2), 169-176, 2017
942017
Multiple clinical vertebral fractures following denosumab discontinuation
AD Anastasilakis, P Makras
Osteoporosis International 27, 1929-1930, 2016
922016
High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas
GP Piaditis, GA Kaltsas, II Androulakis, A Gouli, P Makras, D Papadogias, ...
Clinical endocrinology 71 (6), 772-778, 2009
902009
Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly
GA Kaltsas, II Androulakis, K Tziveriotis, D Papadogias, A Tsikini, ...
Clinical endocrinology 67 (6), 917-922, 2007
842007
Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment
AD Anastasilakis, MP Yavropoulou, P Makras, GT Sakellariou, ...
European journal of endocrinology 176 (6), 677-683, 2017
812017
Medical treatment of hypercalcaemia
P Makras, SE Papapoulos
Hormones 8, 83-95, 2009
812009
Skeletal diseases in Cushing’s syndrome: osteoporosis versus arthropathy
G Kaltsas, P Makras
Neuroendocrinology 92 (Suppl. 1), 60-64, 2010
762010
The system can't perform the operation now. Try again later.
Articles 1–20